FUJIFILM Irvine Scientific, a FUJIFILM Corp. company, recently completed its purchase of Warminster-based Shenandoah Biotechnology for an undisclosed amount.
FUJIFILM Irvine Scientific develops and manufactures serum-free and chemically defined cell culture media for life science research, bioproduction, and cell therapy manufacturing.
“FUJIFILM Irvine Scientific is committed to helping customers bring advanced therapies to market faster and to use innovation to make therapies more accessible,” Yutaka Yamaguchi, FUJIFILM Irvine Scientific chairman and CEO, said earlier this month. “Shenandoah Biotechnology’s portfolio of recombinant proteins complement our advanced cell culture solutions and expertise in bioprocessing, providing our collective customers a single point of access for their life science research, discovery, and cell and gene therapy needs. This acquisition will be an important step toward achieving sales target of ($850 million) in Fujifilm’s Life Sciences Business by FY2025.”
Recombinant proteins are used in a variety of life science applications. To manufacture them, engineered DNA is cloned into expression systems for the large-scale production of proteins.
Shenandoah Biotechnology manufactures cytokines and growth factors along with other recombinant proteins. These types of recombinant proteins are used in cell therapy, gene therapy, and regenerative medicine in the areas of research, development, and manufacturing.
The company’s work complements FUJIFILM Irvine Scientific, Inc.’s advanced cell culture solutions and expertise in bioprocessing.